- Language: English
- 959 Pages
- Published: April 2015
- Region: Global
Analysis on the Chinese Anti-Depression Medicine Market and the Brief Analysis on the Global Market
- ID: 45974
- February 2004
- Region: Asia, China
- 20 Pages
- Sunfaith China Ltd
The report gives an analysis on Chinese anti-depression medicine market. At the beginning of the report, it first gives a brief introduction to the basic situation of the Chinese anti-depression medicines. Anti-depression medicines are mainly Western medicines. We can see from the statistics collected from the sample hospitals in the 14 major cities in China that the five major anti-depression medicines are as follows: namely, fluoxetine, Paxil, Clomipramine, Sertralinum and venlafaxine; meanwhile, it also points out that the imported medicines and that produced by the joint ventures hold the major market share.
Later in the report, it gives an analysis on the application situation of the major anti-depression medicines and new products and points out the rapid development of the Chinese anti-depression medicine market.
At the end of the report, it states that although the overall market scale of Chinese anti-depression medicines is relatively small, the growth rate is rapid. It could be forecasted that the market potential of Chinese anti-depression medicines will be fairly large.
1.1 Statistics on the use of the anti-depression medicines from five hospitals in Shanghai
1.2 Basic situation of the anti-depression medicines in Guangzhou
2. Analysis on the general variety of the anti-depression medicines
2.1 Major anti-depression medicines and the analysis on its market
2.2 Anti-depression live extract
2.3 Introduction of the anti-depression medicines newly appeared in the market
3. Brief introduction to Chinese anti-depression medicines market